Stockscreener 앱 받기
411.49
2.26%
9.11
전일 마감가:
$402.38
열려 있는:
$405.45
하루 거래량:
965.43K
Relative Volume:
1.23
시가총액:
$32.79B
수익:
$3.90B
순이익/손실:
$887.87M
주가수익비율:
38.57
EPS:
10.67
순현금흐름:
$798.08M
1주 성능:
+7.77%
1개월 성능:
-2.57%
6개월 성능:
-10.55%
1년 성능:
-13.96%
1일 변동 폭
$402.86
$412.62
1주일 범위
$375.06
$412.62
52주 변동 폭
$356.14
$548.88
아이덱스 래버러토리스 Stock (IDXX) Company Profile
명칭
Idexx Laboratories Inc
전화
(207) 556-0300
주소
ONE IDEXX DRIVE, WESTBROOK, ME
IDXX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
아이덱스 래버러토리스 Stock (IDXX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-12-04 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2023-08-02 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2022-05-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-08 | 개시 | Atlantic Equities | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-02-17 | 개시 | Barclays | Overweight |
| 2019-09-09 | 개시 | Goldman | Neutral |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2018-11-02 | 재확인 | BofA/Merrill | Buy |
| 2018-05-07 | 재확인 | Stifel | Buy |
| 2018-01-16 | 개시 | Piper Jaffray | Overweight |
| 2017-08-23 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | 업그레이드 | CL King | Neutral → Buy |
| 2017-02-03 | 다운그레이드 | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 재개 | BofA/Merrill | Neutral |
| 2016-08-16 | 재확인 | Stifel | Buy |
| 2016-08-03 | 업그레이드 | Northcoast | Sell → Neutral |
| 2016-07-20 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-19 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-01 | 개시 | CL King | Neutral |
| 2016-03-21 | 재확인 | Stifel | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2015-10-29 | 재확인 | Stifel | Buy |
| 2015-08-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 재확인 | Stifel | Buy |
| 2015-07-23 | 재확인 | Canaccord Genuity | Buy |
모두보기
아이덱스 래버러토리스 주식(IDXX)의 최신 뉴스
Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $548 From $559, Keeps Overweight Rating - MarketScreener
Idexx Laboratories (IDXX): Morgan Stanley Adjusts Price Target, Maintains Overweight Rating | IDXX Stock News - GuruFocus
Stifel Adjusts Price Target for Idexx Laboratories (IDXX) Amidst Innovation Analysis | IDXX Stock News - GuruFocus
Stifel Adjusts IDEXX Laboratories' PT to $420 From $450, Keeps Hold Rating - MarketScreener
IDEXX Laboratories: I Love The Business, Not The Stock Price (NASDAQ:IDXX) - Seeking Alpha
IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains? - Yahoo Finance
IDEXX Laboratories (NasdaqGS:IDXX) Price Moves -14% Over The Last Week Amid Market Volatility - Yahoo Finance
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
Should You Sell IDEXX Laboratories (IDXX)? - MSN
How Is The Market Feeling About IDEXX Laboratories? - Benzinga
IDEXX Laboratories to Release 2025 First Quarter Financial Results - 01net
Pet Healthcare Leader IDEXX Sets Key Q1 2025 Earnings DateWhat Analysts Are Watching - Stock Titan
US judge dismisses most of consumer lawsuit over veterinary service prices - Reuters
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease - simplywall.st
Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000 - Yahoo Finance
Form DEF 14A IDEXX LABORATORIES INC For: Dec 31 - StreetInsider.com
Howe & Rusling Inc. Buys New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Is IDEXX Laboratories, Inc. (IDXX) The Best Pet Stock to Buy According to Billionaires? - Insider Monkey
8 Best Pet Stocks to Buy According to Billionaires - Insider Monkey
Why IDEXX Laboratories, Inc. (IDXX) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey
IDEXX Laboratories Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - Yahoo Finance
12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey
Idexx's Economic Moat Remains Solid, but Softer Consumer Confidence Could Weigh on Near Term - Morningstar
Should You Retain IDEXX Stock in Your Portfolio for Now? - TradingView
IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To ‘Buy’ (NASDAQ:IDXX) - Seeking Alpha
Is IDEXX Laboratories Stock Underperforming the Nasdaq? - Nasdaq
The total return for IDEXX Laboratories (NASDAQ:IDXX) investors has risen faster than earnings growth over the last five years - Simply Wall St
Is IDEXX Laboratories Stock Underperforming The Nasdaq? - Barchart
Jones Financial Companies Lllp Sells 194 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Insider Monkey
Two Texas solar plants serve four buyers through energy attribute certificates - pv magazine USA
X-ELIO closes six US PPAs with Cisco, Biogen, IDEXX, and Waters Corporation - Morningstar
IDEXX Laboratories: A Top Dog In The Pet Care Market (NASDAQ:IDXX) - Seeking Alpha
Steward Partners Investment Advisory LLC Purchases 218 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Oppenheimer & Co. Inc. - Defense World
IDEXX Laboratories, Inc. to Host Earnings Call - ACCESS Newswire
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Assetmark Inc. - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Cut to Hold at StockNews.com - Defense World
Idexx (IDXX) Down 5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
FFT Wealth Management LLC Makes New $227,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Illinois Municipal Retirement Fund Sells 1,017 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Sigma Planning Corp - MarketBeat
738 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Bought by JFG Wealth Management LLC - MarketBeat
Amalgamated Bank Sells 684 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Upgraded by StockNews.com to "Buy" Rating - MarketBeat
Sterling Investment Advisors Ltd. Buys New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Raises Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Sabal Trust CO Makes New Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Wealthspire Advisors LLC Sells 1,358 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
아이덱스 래버러토리스 (IDXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이덱스 래버러토리스 주식 (IDXX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Smith Martin Alexander | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
1,231 |
0 |
1,766 |
| Schreck Michael | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
1,459 |
0 |
2,397 |
| MAZELSKY JONATHAN JAY | President and CEO |
Feb 14 '25 |
Option Exercise |
0.00 |
2,747 |
0 |
84,505 |
| Lane Michael | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
885 |
0 |
7,375 |
| Johnson Michael Perkins | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
355 |
0 |
585 |
| Hunt Nimrata | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
872 |
0 |
12,595 |
| FENNELL GEORGE | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
304 |
0 |
8,480 |
| Erickson Michael G | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
557 |
0 |
21,393 |
| Erickson Michael G | Executive Vice President |
Feb 11 '25 |
Option Exercise |
67.85 |
1,544 |
104,760 |
20,836 |
| FENNELL GEORGE | Executive Vice President |
Feb 10 '25 |
Option Exercise |
79.54 |
9,986 |
794,286 |
18,162 |
0.21%
자본화:
|
볼륨(24시간):